We tested the relation of perceived criticism (PC) from a parent or spouse/romantic partner to outcome of psychotherapy for panic disorder (PD). Method: Participants were 130 patients with PD (79% with agoraphobia) who received 24 twice-weekly sessions of panic-focused psychodynamic psychotherapy, cognitive-behavioral therapy, or applied relaxation therapy. Patients were predominantly White (75%), female (64%), and non-Hispanic (85%). At baseline, Week 5 of treatment, termination, and at 6-and 12-month follow-up, patients rated PC from the relative with whom they lived. Independent evaluators assessed the severity of PD at baseline, Weeks 1, 5, and 9 of treatment, termination, and the 2 follow-up points. Data were analyzed with piecewise (treatment phase, follow-up phase) latent growth curve modeling.
an intervention designed to reduce EE (e.g., Miklowitz et al., 2009) , whereas no additive benefit is observed for low EE families. These findings seem to have had less impact on clinical practice than they warrant, perhaps because assessment of EE by the traditional method, the Camberwell Family Interview (CFI: Vaughn & Leff, 1976) , an interview conducted with the relative in the patient's absence, is lengthy, and scoring is time consuming and requires considerable training. Masland and Hooley (2015) propose that the Perceived Criticism Measure (PCM; Hooley & Teasdale, 1989 ) offers a solution for this science-practice gap. In two studies Hooley & Teasdale, 1989) , this single-item measure ("How critical do you think your relative is of you?"), completed by the patient, proved a better predictor of treatment outcome than the CFI. EE, as assessed by the CFI, taps relatives' attitudes toward the psychiatric patients with whom they live, and it is assumed that these attitudes are reflected in actual behavior toward the patients, an assumption with empirical support (e.g., Hooley, 1986) . Why then might the PCM outperform measures of EE in predicting treatment outcome? Hooley and Teasdale (1989) suggest two reasons: First, that the PCM might draw upon a larger sample of the relative's behavior toward the patient and therefore provide a more reliable assessment, and second, that the PCM might assess the degree to which the relative's criticism gets through to the patient and is therefore distressing.
Since the original Hooley and Teasdale (1989) study of posthospitalization relapse in women with major depression, at least 15 additional studies on PCM as a predictor of outcome have been published with mixed results. PCM has predicted (a) failure to improve during treatment; or (b) symptom worsening or relapse after treatment in patients with anxiety disorders, drug use disorders, bipolar disorder, major depression, and prodromal psychosis. However, there are just as many failures to replicate. This literature is summarized in supplemental material Table 1 .
Examination of the PCM literature reveals a body of research plagued with methodological problems, including, but not limited to, studies' being adequately powered for only very large effect sizes, no demonstration of interrater reliability for critical interview measures of outcome, reliance upon completer samples with no use of methods to accommodate missing data, and failure to account for the effects of symptom severity at initial assessment. Under such circumstances muddled findings are to be expected. Mixed findings also suggest there may be important unmeasured moderators of the PCM-outcome link. Renshaw (2007) demonstrated that PCM only predicts symptom change over time when (a) respondents live with the people they rate on the PCM (which likely increases hours of contact substantially), and (b) those people are parents or spouses/romantic partners. However, frequency of contact and type of PCM target does not account for all replication failures. The state of the PCM literature and the small number of studies on disorders other than major depression argue for further research on PCM designed to avoid the identified methodological limitations.
If EE and PC do predict worse outcomes for patients, why is this the case? The most widely accepted theory is that EE and PC are indicators of a stressful family environment that triggers symptom exacerbation in vulnerable patients (Hooley & Gotlib, 2000) . There is some evidence that this is the case (e.g., Steketee, Lam, Chambless, Rodebaugh, & McCullough, 2007) . An alternative hypothesis is that the EE/PC link with outcome is artifactual, with EE/PC merely reflecting symptom severity, which is, in turn, linked to worse outcome (e.g., Turner, 1998) . If so, we would expect the PCM to be correlated with symptom severity at initial assessment and to covary with symptom severity across treatment and follow-up. Renshaw (2008) reviewed evidence debunking the notion that the PCM is related to initial symptom severity, but researchers have seldom examined whether PC and symptom severity covary across treatment. It seems unlikely, in that the available evidence indicates that the PCM is quite stable across months of treatment (r ϭ .66, Renshaw, Chambless, & Steketee, 2003) or treatment and follow-up (r ϭ .75; Hooley & Teasdale, 1989) , but more studies on this point are needed. In the one study of the relation of symptom severity to change on PCM across treatment, Renshaw et al. (2003) found that concurrent PCM was not significantly correlated with symptom severity for anxiety disorder patients either before or at the end of treatment, that initial symptom severity did not predict changes in PCM over time, but that initial PCM predicted change in symptom severity across treatment. This study was limited in two ways: (a) the authors only included patients with complete data at both assessment points, thus possibly biasing results through omission of 20% of the sample; and (b) they only assessed symptom severity and PCM at two time points (before and after treatment), hence failing to capture the follow-up interval and providing insufficient data points to adequately model covariation in the change processes of these two variables.
The present study was designed to provide a more carefully controlled assessment of the PCM-outcome link, permitting a further test of PCM as a predictor of treatment outcome in PD and allowing tests of the alternative hypotheses previously described. PD provides fertile ground for the effects of EE/PC. The onset of PD frequently occurs in a context of interpersonal stress (see review by Chambless, 2010) . Once the disorder is established, PD may strain the patient-relative relationship: When patients are agoraphobic, they may require relatives' assistance for many aspects of daily living and may restrict family life because of their phobic avoidance. Even when agoraphobia is not present as a complication, PD can burden relatives because patients may seek repeated assurance that they are not in danger (e.g., of a heart attack) when having a panic attack; for example, waking the relative at night for reassurance during a nocturnal panic attack or involving the relative in frequent trips to the emergency room. Empirical findings suggest relationship stress affects treatment outcome in this population. In a retrospective study of the relationship of chronic stress to treatment outcome for PD with agoraphobia, Wade, Monroe, and Michelson (1993) found that interpersonal stress was the most common stressor reported and that interpersonal conflict was related to worse outcome on symptom and global functioning measures. More pertinent to the present study, in the one study of EE/PC including patients with PD of which we are aware, found that both the CFI and the PCM predicted poorer response to behavior therapy. In a process study of this sample Steketee et al. (2007) found that PC during treatment of PD with agoraphobia predicted increased fear of phobic situations during exposure treatment sessions. In light of the paucity of EE/PC research on anxiety disorders relative to that on depression and schizophrenia, these findings are well worth pursuing. This document is copyrighted by the American Psychological Association or one of its allied publishers.
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To accomplish our aims, we drew upon data from our study of psychotherapy for PD (Milrod et al., 2015) in which we compared the effects of three types of psychotherapy-panic-focused psychodynamic psychotherapy, applied relaxation, and panic control therapy (a version of cognitive-behavioral therapy).We collected reliable measures of PC and PD severity across treatment and follow-up phases of the study, and we included the full intentionto-treat sample of those patients living with a parent or spouse/ partner. Based on theory and our prior findings, we hypothesized that initial PC would predict change in PD severity. However, we also tested the alternative hypotheses that (a) initial PD severity would predict changes in PC, and (b) changes in PC and changes in PD severity would covary across the course of the trial. We used latent growth curve modeling with maximum likelihood estimation of missing data for these tests. In the process, we investigated the stability of the PCM across treatment.
Method
More complete details on procedures are available in the paper on the parent trial (Milrod et al., 2015) . Here we focus on procedures pertinent to the current research questions.
Participants
Of the 200 patients participating in the parent study (Milrod et al., 2015) , 130 were living with a spouse/partner or parent and are included in the present study. Table 1 lists descriptive data. Patients were recruited via referrals from health care professionals, the study website, flyers, and advertisements. Inclusion criteria included a Diagnostic and Statistical Manual of Mental Disorders (4th ed.; DSM-IV; American Psychiatric Association, 1994) primary diagnosis of PD with or without agoraphobia and Ն1 spontaneous panic attacks per week for the month before entry. Psychotropic medication was permitted if stable for Ն2 months at intake and if the patient was willing for it to remain constant across the trial and the 12-month follow-up period. Exclusion criteria included active substance dependence (Ͻ6 months' remission), history of psychosis or bipolar disorder, acute suicidality, organic mental syndrome, evidence of medical conditions that might cause the patient's symptoms, involvement in legal or disability proceedings involving the patient's mental state, and unwillingness to forego nonstudy psychotherapy for the duration of the active treatment and follow-up phases of the protocol. Patients were included regardless of their previous history of experience with the treatments tested. Patients were seen at the Perelman Medical School of the University of Pennsylvania or Weill Medical College of Cornell University. The study was approved by the institutional review board at each institution, and all patients provided written informed consent. Patients' characteristics, including the frequency of comorbid disorders, are described in Table 1 . Patients were compensated in the amount of $100 for completion of their 12-month follow-up assessment. 1
Measures
Panic Disorder Severity Scale (PDSS). This 7-item interview covers frequency of panic attacks, anticipatory anxiety, avoidance of situations and of bodily sensations that trigger panic, and impairment due to panic in work and social spheres (Shear et al., 1997) . Independent evaluators interviewed patients with the PDSS at baseline, Weeks 1, 5, and 9 of treatment, termination, and 6-and 12-month follow-up. Interrater reliability was excellent, r I ϭ .95.
PCM. The PCM (Hooley & Teasdale, 1989) criticism item is rated on a scale ranging from 1 (not at all) to 10 (very critical). When patients lived with both parents, we followed EE/PC tradition and used the PCM from the more critical parent. The PCM was administered at baseline, Week 5 of treatment, termination, and 6-and 12-month follow-up. The PCM has proved to have good test-retest reliability, moderate agreement with relatives' own reports of their criticism of the patient, and good agreement with objective raters of relatives' criticism of the patient in face-to-face interactions (see review by Renshaw, 2008) . In the present sample, the test-retest reliability coefficient for the PCM over approximately five months from baseline to termination of treatment was large, r ϭ .58, p Ͻ .001, although smaller than that reported by Hooley and Teasdale (1989) and Renshaw et al. (2003) .
Procedure
Patients were randomly assigned to panic-focused psychodynamic psychotherapy (Milrod, Busch, Cooper, & Shapiro, 1997) , panic control therapy (a form of cognitive-behavioral therapy; Craske, Barlow, & Meadows, 2000), or applied relaxation training (Schwalberg & Chambless, 2006 ) in a 2:2:1 ratio. Ordinarily patients received 24 sessions on a twice-weekly basis. However, because panic control therapy and applied relaxation therapy were highly focused on panic and avoidance, there was a provision for planning termination after 19 sessions for patients in these conditions if they had improved to the extent that no further treatment for these problems seemed required. To achieve an adequate sample size for the present analyses, we ignore treatment assignment.
Patients were followed, regardless of treatment completion, until 12-month follow-up or until (a) they violated the study protocol by engaging in other psychotherapy, by altering the dosage of any psychotropic medications on which they started treatment, or by adding new medications (n ϭ 22); (b) they refused further follow-up or could not be located (n ϭ 56); or (c), at one site, until project funds were exhausted (n ϭ 5). Six patients were excluded from the follow-up but not the acute phase for the following reason: due to ethical concerns, if patients did not respond to treatment (defined by convention as Ն40% decrease on the PDSS scores; (Barlow, Gorman, Shear, & Woods, 2000) , they were offered one of the other two treatments in the protocol. Of the 49 patients in the present sample who were not treatment responders, these six patients availed themselves of this option and, as a result, were in a second active treatment phase during the follow-up period. However, the results are little changed by inclusion of these patients.
Results

Data Analysis
Based on visual inspection of the trajectories of PCM and PD severity over the course of the trial (see supplemental Table 2), we 1 At one site patients were also compensated $20 for the 6-month follow-up. This document is copyrighted by the American Psychological Association or one of its allied publishers.
estimated a series of piecewise linear latent growth curve models in which the first linear slope represented change from baseline to termination (treatment slope) and the second linear slope represented change from termination to 12-month follow-up (follow-up slope) in our variables of interest, as well as the latent intercepts of each at baseline. First, separate unconditional models for PCM and PD severity were conducted to determine variability in the latent intercepts and slopes for these variables. A conditional model was then conducted to test study hypotheses. All latent growth curve analyses were conducted in Mplus using maximum likelihood estimation for missing data (Muthén & Muthén, 2007) . Of the total possible data points, 304/650 on the PCM and 271/910 on the PDSS were missing in the present sample for the reasons detailed in the Procedure section or because patients skipped an assessment. For each patient we calculated two variables representing the total amount of missing data points for PCM and for PDSS and examined the relation between PCM and PDSS missingness and latent variables of interest. There proved to be no significant relation between missingness and the slope factors in any model, thus reducing concerns about bias in the critical data representing change. Because missingness was related to the PDSS intercept, we retain the missing data variables in the conditional model. The full correlation matrix may be found in supplemental Table 3 .
Latent Growth Curve Analyses
Unconditional models. The unconditional piecewise linear growth model for the PDSS fit the data moderately well (fit statistics and latent factor means and variances for unconditional models are shown in Table 2 ). The mean estimate was significant for the treatment slope but not the follow-up slope. Thus, as a group, patients changed significantly during the acute phase of treatment and maintained but did not increase their improvement in follow-up. Of critical importance if prediction of change is to be possible, significant variability was found in both the treatment and follow-up slopes.
For PCM, fit of the unconditional piecewise linear growth model was excellent. The mean estimate was not significant for either the treatment or follow-up slope. Significant variability was observed in the intercept but not the slopes. Taken together, these findings indicate that PCM remained stable across time and individuals. Thus, the alternative hypotheses that initial PD severity predicts changes in PCM or that changes in PCM covary with changes in PD severity are untenable.
Hypothesis testing. We estimated a conditional piecewise linear growth model in which (a) the PCM latent intercept predicted the treatment and follow-up latent slopes for PDSS, (b) the intercept and slopes of the PDSS were allowed to covary with the PCM intercept and slopes, and (c) the missingness variables were allowed to covary with the intercepts and slopes of their respective variables along with one another. Given our hypothesis that the PCM intercept would predict worse outcome during treatment and follow-up, single-tailed tests of significance were conducted for these paths (Figure 1) . Model fit to the data was adequate 2 (see Table 2 ). Results showed that the PCM latent intercept (baseline) significantly predicted the follow-up 2 Based on examination of modification indices and upon rationale, we permitted a correlation to be estimated between adjacent PDSS data points between Weeks 1 and 5 and between Weeks 5 and 9 so that the model would converge. This article is intended solely for the personal use of the individual user and is not to be disseminated broadly.
slope but not the acute treatment slope for PD severity, indicating that patients who reported greater initial levels of PC experienced greater increases in PD severity during follow-up than those with lower initial PC. As would be expected from the lack of variability in the PCM slopes in the unconditional model, the PDSS latent intercept was not significantly associated with the PCM slopes in either phase, nor did the PCM and PDSS slopes covary significantly. Analysis of the full intention-to-treat sample, including in the follow-up phase the six patients we treated during follow-up, were entirely consistent with these findings. See supplemental Tables 3  and 4 
Discussion
Consistent with the study hypothesis, higher PC predicted worse treatment outcome for PD. In contrast, the alternative hypotheses that higher PD severity before treatment would predict less change on perceived criticism or that PC and PD severity would covary across treatment and follow-up were not supported. Our results are in keeping with other research finding that PCM predicted symptom exacerbation or relapse in the follow-up period after treatment (see supplemental Table 1 ). However, they are partly inconsistent with the one prior study on anxiety disorders, in which PCM predicted less change during active treatment but not symptom change in the follow-up period for those who initially responded to treatment Steketee & Chambless, 2001) .
3 Why our results would deviate from those of the earlier study is not clear, but there were a number of procedural differences between the two research projects. For example, Chambless and Steketee analyzed the PCoutcome relation for the acute phase for treatment completers only (having shown PCM did not predict dropout) and, for the follow-up phase (Steketee & Chambless, 2001) , only for those who had met criteria for reliable change on fear and avoidance at termination. In the present study, we focused on change in PD severity with a broader measure that assessed disability, anticipatory anxiety, and frequency and severity of panic attacks as well as phobic avoidance, and we included the entire intention-to-treat sample 4 from pretest to followup, using modern techniques to estimate missing data.
The findings of the present study add to the literature on EE/PCM effects on treatment outcome with anxiety and related disorders. found that both PCM and CFIassessed hostility predicted less change in fear and avoidance of patients with obsessive-compulsive disorder and PD with agoraphobia treated with behavior therapy. Similarly, Tarrier, Sommerfield, and Pilgrim (1999) found that CFI-assessed criticism and hostility predicted a worse response to cognitive-behavioral therapy among patients with posttraumatic stress disorder. Although not a direct test of the diathesis-stress hypothesis of EE/PC's effects, the present findings, along with those of the prior studies, are consistent with this hypothesis. They suggest that given a stressful home environment in which the patient perceives criticism from important attachment figures, PD patients do not fare as well in the follow-up period once the support of twice-weekly psychotherapy sessions has been withdrawn. How might this work? Modeling data from weekly diaries of patients in Chambless and Steketee's trial, Steketee et al. (2007) found that PC predicted how upset the patient was by that criticism, which, in turn, predicted greater anxious and depressed mood. These negative mood states were then associated with higher levels of anxiety when patients were confronted with the situations they feared and avoided in treatment sessions. Thus, stress in the home environment appears to be translated into higher anxiety in response to anxiety-provoking stimuli. During the acute treatment phase the therapist's active support of the patient and encouragement to confront phobic stimuli even though anxious may have overridden the effects of a stressful interpersonal environment, but once the treatment ended this counterbalancing effect would have been lost.
There are a number of limitations to this research: First, there was a substantial amount of missing data, which we addressed by maximum likelihood estimation and by demonstrating that the amount of missing data for PCM and for PDSS was not related to the slopes of change for either variable. Under such circumstances, it is likely that the path coefficients were unbiased (Graham, 2009) . Nonetheless, we cannot be assured that the findings would have been the same had we had complete data. Second, our sample was too small to allow us to test whether the findings varied across types of treatment. The lack of change and variability in the PCM slopes indicates it is unlikely that the treatments were differentially effective in changing PCM, but we cannot rule out differential effectiveness in immunizing patients to Note. PCM ϭ Perceived Criticism Measure. Given the sensitivity of chi square tests to sample size, we rely upon the root-mean-square error of approximation (RMSEA) and comparative fit index (CFI) for interpretation of model fit.
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PCM. Nonetheless, from a methodological viewpoint, this is one of the strongest studies in the PCM literature and one of a very few to test PCM's effects in the context of psychotherapy rather than medication and clinical management. Third, our data, like other PCM data, are correlational and thus do not prove that PC is a causal factor in poorer treatment outcome. Fourth, there are limitations to our use of the single-item PCM. The brevity of the PCM is a boon for use in clinical settings. However, this global rating provides no detail about what aspects of criticism patients find most distressing and that, therefore, might be most closely linked to treatment outcome. Renshaw, Blais, and Caska (2010) have suggested that it is valuable to separate perceived constructive and destructive criticism, with the latter being more highly correlated with the standard PCM. It might also be useful to obtain information about the frequency and intensity of PC as well as what characteristics or behaviors on the patient's part were likely to be targets of relatives' criticism. For example, criticisms about the patient's character or personality might be more toxic than those focused on specific behaviors-a distinction akin to that between hostility and criticism, respectively, on the CFI (Vaughn & Leff, 1976) . More richly detailed information of this type would be valuable in guiding clinical intervention. Finally, we did not comprehensively measure family variables that have been linked to treatment outcome for anxiety disorders. found that another component of EE tapped by the CFI, namely, the relative's emotional overinvolvement with the patient, predicted premature treatment termination among patients with obsessive-compulsive disorder and PD with agoraphobia. Emotional overinvolvement is minimally correlated with criticism and hostility on the CFI and with the PCM (Chambless, Bryan, Aiken, Steketee, & Hooley, 1999) .
5 Because we did not include a measure of this construct, our findings are likely to underestimate the impact of the patients' family environment on treatment outcome of PD.
Taken in context with other studies supporting the PCMoutcome link, our findings argue for the inclusion of significant others in treatment when PCM is high, presuming this is consistent with the therapist's theoretical model. Family therapy protocols have been developed to reduce EE (e.g., Miklowitz, 2008) and recent evidence indicates such treatment reduces PC as well (O'Brien, Miklowitz, & Cannon, 2015) . In contrast, consistent This document is copyrighted by the American Psychological Association or one of its allied publishers. This article is intended solely for the personal use of the individual user and is not to be disseminated broadly.
with the results of Renshaw et al. (2003) , in the present study PC did not change in individual therapy targeting PD. Chambless (2012) has developed a couple/family therapy designed as an adjunct to individual cognitive-behavioral therapy for patients with anxiety disorders that includes a specific focus on PC as well as EE. Whether this treatment will be effective in reducing PC and negative outcomes for PD patients must be determined by controlled research.
